These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 12358145

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of matrix metalloproteinase-9 activity by trandolapril after middle cerebral artery occlusion in rats.
    Tanaka H, Takai S, Jin D, Furubayashi K, Inoue N, Kajimoto Y, Miyatake S, Kuroiwa T, Miyazaki M.
    Hypertens Res; 2007 May; 30(5):469-75. PubMed ID: 17587759
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trandolapril dose-response in spontaneously hypertensive rats: effects on ACE activity, blood pressure, and cardiac hypertrophy.
    Jouquey S, Stepniewski JP, Hamon G.
    J Cardiovasc Pharmacol; 1994 May; 23 Suppl 4():S16-8. PubMed ID: 7527096
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
    Koffi I, Lacolley P, Kirchengaast M, Pomiès JP, Laurent S, Benetos A.
    Eur J Pharmacol; 1998 Nov 13; 361(1):51-60. PubMed ID: 9851541
    [Abstract] [Full Text] [Related]

  • 9. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
    Pedersen OD, Gram J, Jeunemaitre X, Billaud E, Jespersen J.
    Coron Artery Dis; 1997 May 13; 8(5):283-91. PubMed ID: 9285181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats.
    Weinstein PR, Anderson GG, Telles DA.
    Stroke; 1986 May 13; 17(2):318-24. PubMed ID: 3961841
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Protective effects of minaprine in infarction produced by occluding middle cerebral artery in stroke-prone spontaneously hypertensive rats.
    Okuyama S, Shimamura-Harada H, Karasawa Y, Kawashima K, Araki H, Kimura M, Otomo S, Aihara H.
    Gen Pharmacol; 1991 May 13; 22(1):143-50. PubMed ID: 1675616
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme.
    Chevillard C, Brown NL, Mathieu MN, Laliberté F, Worcel M.
    Eur J Pharmacol; 1988 Feb 16; 147(1):23-8. PubMed ID: 2836219
    [Abstract] [Full Text] [Related]

  • 19. Regional cerebral blood flow after occlusion of the middle cerebral artery.
    Olsen TS.
    Acta Neurol Scand; 1986 Apr 16; 73(4):321-37. PubMed ID: 3524091
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.